Anti-RBD-6 antibody (VHH-72)

Reference: PTXCOV-A554
size

100µg

Brand

Product type

Clonality

Product nameAnti-RBD-6 antibody (VHH-72)
SpeciesHuman
Expression systemMammalian
Molecular weight39,2kDa
Purity85%
BufferPBS, pH7,5
FormLiquid
Delivery conditionBlue ice (+4°C)
Storage condition4°C for short term; -20°c or -80°C for long term
BrandProteogenix
ApplicationsELISA,WB
Aliases /SynonymsVHH-72 antibody
ReferencePTXCOV-A554
NoteFor research use only. Not suitable for in vitro diagnostic and human use.
IsotypeIgG1
ClonalityMonoclonal Antibody
TargetRBD domain- SARS-CoV2 Spike protein

Description of Anti-RBD-6 antibody (VHH-72)

General information on Anti-RBD-6 antibody

Antibody anti-RBD-6 is a single-domain camelid heavy chain immunoglobulin (VHH, nanobody). It was developed by immunizing a llama with stabilized spike proteins from coronaviruses MERS-CoV and SARS-CoV-1. After immunization and development of a measurable immune response, the RNA was isolated from the peripheral blood mononuclear cells (PBMCs) and used as a template for cDNA synthesis and amplification of the antibody genes.
The resulting library of antibodies was screened by phage display with Escherichia coli and M13 helper phages against the spike protein of SARS-CoV-1. Binders with the highest affinity were screened for cross-reactivity with the spike protein of the new coronavirus and selected for further studies. The anti-RBD-6 antibody displayed a high affinity towards the spike proteins of SARS-CoV-1 and SARS-CoV-2. Crystallization studies further revealed this antibody binds a conserved region of the receptor-binding domain (RBD) shared between the two SARS strains. Additional studies with pseudotyped viral particles showed that the anti-RBD-6 antibody in a monovalent format (VHH) displayed only a mild neutralizing activity against these viruses.
Due to its initially feeble activity, the monovalent VHH was further engineered into a bivalent conformation (VHH-VHH). This format succeeded in enhancing this molecule’s neutralizing activity.
VHH antibodies are valuable reagents due to their enhanced chemo and thermostability in comparison to conventional antibodies. They are also easier to produce in vitro due to the absence of glycans on their surface. Moreover, they display higher diffusion rates making their ideal reagents for diagnostics and therapeutic applications. In this context, this bivalent VHH molecule can serve to investigate SARS-CoV-2 mechanisms of infection, develop robust in vitro diagnostic tools, and used for medical imaging when conjugated with the adequate molecular markers.

SDS-PAGE for Anti-RBD-6 antibody

Anti-RBD-6 antibody (VHH-72), on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Anti-RBD-6 antibody (VHH-72)”

Your email address will not be published. Required fields are marked *

Related products

Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 180€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products